Clinical Trials
29 trialsCollecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Alliance for Clinical Trials in Oncology
iCaRe2
University of Nebraska
Evaluation for NCI Surgery Branch Clinical Research Protocols
National Institutes of Health Clinical Center (CC)
DP-04
AstraZeneca
ELEPHAS-02
Elephas
CER
Cancer Support Community, Research and Training Institute, Philadelphia
TraveraRTGx
Travera Inc
ELEPHAS-05
Elephas
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Massive Bio, Inc.
ORACLE
Guardant Health, Inc.
DELFI-L101
Delfi Diagnostics Inc.
Tempus Priority Study: A Pan-tumor Observational Study
Tempus AI
Serpentine
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Associations Between Chemotherapy-Induced Nausea in Patients With Genitourinary, Sarcoma or Melanoma Cancers and Changes in Gut Microbiome: Potential for Precision Therapeutics
Mayo Clinic
Genomic Testing and Resulting Medical Decisions
Arbeitsgemeinschaft medikamentoese Tumortherapie
EVIDENT
Sheffield Teaching Hospitals NHS Foundation Trust
ROOT
Taproot Health
SkinHealth
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
A Tissue Collection Study in Patients Who Respond to Immune Checkpoint Inhibitors to Identify Targets of Tumor-Reactive T Cells.
TScan Therapeutics, Inc.
PIONEER
SpeciCare
The Molecular Predisposition to Hereditary Nonpolyposis Colon Cancer (HNPCC)
M.D. Anderson Cancer Center
E-MOSAIC Electronic Tool to Monitor Symptoms
Swiss Cancer Institute
A Comprehensive Study to Isolate Tumor-initiating Cells From Human Epithelial Malignancies
Stanford University
N1
CureOne
Circulating Tumor DNA Exposure in Peripheral Blood
Quantgene Inc.
Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial
National Institutes of Health Clinical Center (CC)
Laboratory Assay in Determining Cancer Resistance in Patients With Metastatic Cancer and in Healthy Participants
Wake Forest University Health Sciences
OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer
OHSU Knight Cancer Institute
Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom
National Cancer Institute (NCI)